American Society of Clinical Oncology

SHERPA: White

People

  1. Janjigian
    Janjigian
  2. Ilson
    Ilson
  3. Kelsen
    Kelsen
  4. Ku
    Ku
  5. Capanu
    Capanu
  6. Kris
    Kris
  7. Riely
    Riely
  8. Tang
    Tang
  9. Berger
    Berger
  10. Coit
    Coit

Groups

  1. Gastrointestinal Oncology Service (43)
  2. Solid Tumor Oncology Division (43)
  3. Gastrointestinal Disease Management Team (36)
  4. Thoracic Malignancies Disease Management Team (27)
  5. Colorectal Disease Management Team (21)
  6. Epidemiology and Biostatistics (17)
  7. Biostatistics Service (16)
  8. Surgery (12)
  9. Hepatopancreaticobiliary Disease Management Team (11)
  10. Survivorship Research (9)
Search Within
Refine Results
  1. "Yelena Janjigian"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (4)
Groups
  1. Gastrointestinal Oncology Service (43)
  2. Solid Tumor Oncology Division (43)
  3. Gastrointestinal Disease Management Team (36)
  4. Thoracic Malignancies Disease Management Team (27)
  5. Colorectal Disease Management Team (21)
  6. Epidemiology and Biostatistics (17)

More Groups

People
  1. Yelena Janjigian (43)
  2. David Ilson (19)
  3. David Kelsen (18)
  4. Geoffrey Ku (15)
  5. Marinela Capanu (14)
  6. Manish Shah (11)

More People

Years
  1. 2018 (8)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (7)
  5. 2014 (6)
  6. 2013 (7)

More Years

Publications
  1. Journal of Clinical Oncology (43)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials
    Meeting Abstract

    Chau, I.; Chen, L. T.; Kang, Y. K.; Satoh, T.; Kato, K.; Chung, H. C.; Kang, W. K.; Chao, Y.; Chen, J. S.; Ott, P. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
    Meeting Abstract

    Oh, P.; Zhang, M.; Brady, P.; Sihag, S.; Molena, D.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Wu, A. J. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Survival of chemotherapy (chemo) refractory gastric or gastroesophageal junction cancer (GC/GEJC) patients from Flatiron Health (FH): Matched clinical characteristics to ATTRACTION-2 and CHECKMATE-032
    Meeting Abstract

    Janjigian, Y. Y.; Le, D. T.; Ott, P. A.; Korytowsky, B.; Le, H.; Le, T. K.; Zhang, Y.; Sanchez, T.; Maglinte, G.; Laurie, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MORPHEUS: A phase Ib/II multi-trial platform evaluating the efficacy and safety of cancer immunotherapy (CIT)-based combinations in patients (pts) with gastric or pancreatic cancer
    Meeting Abstract

    Manji, G. A.; Bendell, J. C.; Oh, D. Y.; Kim, K. P.; Macarulla, T.; Ponz-SarviseĢ, M.; Ajani, J. A.; Oberstein, P.; Janjigian, Y. Y.; Chau, I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) landscape and prognostic implications in advanced gastroesophageal adenocarcinoma (GEC)
    Meeting Abstract

    Maron, S. B.; Joshi, S. S.; Lomnicki, S.; Oliwa, T.; Landron, S.; Johnson, J.; Kiedrowski, L. A.; Nagy, R. J.; Lanman, R. B.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC)
    Meeting Abstract

    Ku, G. Y.; Mukherjee, S.; Okoro, C.; Sharma, M.; Ravichandran, V.; Offit, K.; Joseph, V.; Janjigian, Y. Y.; Stadler, Z. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials
    Meeting Abstract

    Chau, I.; Chen, L. T.; Kang, Y. K.; Satoh, T.; Kato, K.; Chung, H. C.; Kang, W. K.; Chao, Y.; Chen, J. S.; Ott, P. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • CheckMate-032 Study: Efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Bendell, J.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Ott, P. A.; Peltola, K.; Jaeger, D.; Evans, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • It is time to stop using epirubicin to treat any patient with gastroesophageal adenocarcinoma
    Journal Article

    Elimova, E.; Janjigian, Y. Y.; Mulcahy, M.; Catenacci, D. V.; Blum, M. A.; Almhanna, K.; Hecht, J. R.; Ajani, J. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study
    Meeting Abstract

    Le, D. T.; Bendell, J. C.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Ott, P. A.; Bono, P.; Jaeger, D.; Evans, T. R. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save